Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRME Imaging in Cervical Adenocarcinoma In-Situ
NCT02206048Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2015
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Feasibility of Acquiring In-vivo High-Resolution Microendoscopy (HRME) Images of Cervix Prior to Conization at 1 day. Started Oct 2015; status: completed.
Beyond the preview
Go deeper on NCT02206048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02206048.